{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:06:02Z","timestamp":1792681562831,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2279,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare, Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>The study aims to evaluate the prognostic significance of impaired glucose tolerance (IGT) with reference to albuminuria in patients with chronic heart failure (CHF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We examined 535 CHF patients (mean 66 years, women 25%) in the control arm of our SUPPORT trial, in which we examined additive impact of olmesartan in hypertensive patients with symptomatic CHF treated with \u03b2-blockers and\/or angiotensin-converting enzyme inhibitors. We examined the association between glycaemic abnormality (assessed by 75 g of oral glucose tolerance test) and albuminuria for a composite outcome of all-cause death, myocardial infarction, stroke, and HF hospitalization. IGT patients (N = 113, mean 67.2 years) were older and more frequently treated with \u03b2-blockers compared with those with normal glucose regulation (N = 142, mean 64.0 years) and those with diabetes mellitus (N = 280, mean 65.7 years). Multivariable Cox proportional hazard models revealed that, as compared with normal glucose regulation (NGR), IGT was associated with increased risk of the outcome when complicated by albuminuria [hazard ratio (HR) 2.25; 95% confidence interval (CI) 1.14\u20134.42; P = 0.019] but not when uncomplicated by albuminuria (HR 0.76; 95% CI 0.35\u20131.60, P = 0.47) (P for interaction = 0.041). This was also the case for diabetes mellitus and albuminuria (HR 2.06; 95% CI 1.17\u20133.61; P = 0.012). Among IGT patients without albuminuria, 21 (29%) developed albuminuria at 1-year visit, which was again associated with poor prognosis (HR 7.36; 95% CI 1.39\u201338.98, P = 0.019).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results indicate that IGT is associated with poor prognosis when complicated by albuminuria in CHF patients, demonstrating the importance of combined early stages of glucose intolerance and renal dysfunction in the management of CHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12516","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T13:35:19Z","timestamp":1571924119000},"page":"1252-1261","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impaired Glucose Tolerance and Albuminuria in Patients with Chronic Heart Failure: A Subanalysis of the Support Trial"],"prefix":"10.1093","volume":"6","author":[{"given":"Kotaro","family":"Nochioka","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Seiryo-machi 1\u20131, Sendai, Miyagi, 980\u20138574 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Seiryo-machi 1\u20131, Sendai, Miyagi, 980\u20138574 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Seiryo-machi 1\u20131, Sendai, Miyagi, 980\u20138574 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shiroto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Seiryo-machi 1\u20131, Sendai, Miyagi, 980\u20138574 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Seiryo-machi 1\u20131, Sendai, Miyagi, 980\u20138574 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Saga","sequence":"additional","affiliation":[{"name":"Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Ikeno","sequence":"additional","affiliation":[{"name":"Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shiba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, International University of Health and Welfare Hospital , Tochigi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Shinozaki","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Sendai Medical Center, National Hospital Organization , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Sugi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Iwaki City Medical Center , Fukushima ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Iwate Prefectural Isawa Hospital , Iwate ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Komaru","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku Medical and Pharmaceutical University , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Sendai Open Hospital , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Iwate Prefectural Central Hospital , Iwate ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Iwabuchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaki Citizen Hospital , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hiramoto","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Kurihara Central Hospital , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanichi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Senen Rifu Hospital , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ohe","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Kojirakawa Shieido Hospital , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Cardiology Department, Iwate Health Service Association , Iwate ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, Department of Public Health and Forensic Medicine, Tohoku University Graduate School of Medicine , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Seiryo-machi 1\u20131, Sendai, Miyagi, 980\u20138574 ,","place":["Japan"]},{"name":"Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine , Miyagi ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"2026012115084488100_ehf212516-bib-0001","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/euhj.1999.2043","article-title":"Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure","volume":"21","author":"Suskin","year":"2000","journal-title":"Eur Heart J"},{"key":"2026012115084488100_ehf212516-bib-0002","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacc.2004.03.037","article-title":"Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link","volume":"44","author":"Witteles","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084488100_ehf212516-bib-0003","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1291\/hypres.29.775","article-title":"Abnormal glucose tolerance contributes to the progression of chronic heart failure in patients with dilated cardiomyopathy","volume":"29","author":"Kim","year":"2006","journal-title":"Hypertens Res"},{"key":"2026012115084488100_ehf212516-bib-0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/hrt.2006.110999","article-title":"Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure","volume":"94","author":"Berry","year":"2008","journal-title":"Heart"},{"key":"2026012115084488100_ehf212516-bib-0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurjhf\/hfq216","article-title":"Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis","volume":"13","author":"Egstrup","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026012115084488100_ehf212516-bib-0006","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2005.02.093","article-title":"Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure","volume":"46","author":"Doehner","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084488100_ehf212516-bib-0007","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/CIRCULATIONAHA.108.821843","article-title":"Elevated admission glucose and mortality in elderly patients hospitalized with heart failure","volume":"119","author":"Kosiborod","year":"2009","journal-title":"Circulation"},{"key":"2026012115084488100_ehf212516-bib-0008","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)","volume":"34","author":"Authors\/Task Force M","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012115084488100_ehf212516-bib-0009","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1523-1755.2002.00507.x","article-title":"Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh epidemiology of diabetes complication study","volume":"62","author":"Orchard","year":"2002","journal-title":"Kidney Int"},{"key":"2026012115084488100_ehf212516-bib-0010","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2337\/db05-1484","article-title":"Insulin resistance and microalbuminuria: a cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion","volume":"55","author":"Parvanova","year":"2006","journal-title":"Diabetes"},{"key":"2026012115084488100_ehf212516-bib-0011","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/diabetes.47.5.793","article-title":"Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study","volume":"47","author":"Mykkanen","year":"1998","journal-title":"Diabetes"},{"key":"2026012115084488100_ehf212516-bib-0012","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1253\/circj.CJ-14-0787","article-title":"Investigators C. Prognostic impact of subclinical microalbuminuria in patients with chronic heart failure","volume":"78","author":"Miura","year":"2014","journal-title":"Circ J"},{"key":"2026012115084488100_ehf212516-bib-0013","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcmg.2014.12.020","article-title":"Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the Thousand & 1 study","volume":"8","author":"Jensen","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026012115084488100_ehf212516-bib-0014","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/eurheartj\/ehu504","article-title":"Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial","volume":"36","author":"Sakata","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012115084488100_ehf212516-bib-0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jjcc.2013.02.011","article-title":"Supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial\u2014rationale and design","volume":"62","author":"Sakata","year":"2013","journal-title":"J Cardiol"},{"key":"2026012115084488100_ehf212516-bib-0016","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Expert Committee on the D, Classification of Diabetes M. Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"2026012115084488100_ehf212516-bib-0017","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Kidney disease: improving global outcomes chronic kidney disease guideline development work group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens","year":"2013","journal-title":"Ann Intern Med"},{"key":"2026012115084488100_ehf212516-bib-0018","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(01)01702-8","article-title":"American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)","volume":"38","author":"Cannon","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084488100_ehf212516-bib-0019","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(03)14282-1","article-title":"Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme","volume":"362","author":"Pfeffer","year":"2003","journal-title":"Lancet"},{"key":"2026012115084488100_ehf212516-bib-0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jchf.2014.04.008","article-title":"Risk prediction in patients with heart failure: a systematic review and analysis","volume":"2","author":"Rahimi","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2026012115084488100_ehf212516-bib-0021","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/ejhf.807","article-title":"Characterization of heart failure patients with mid-range left ventricular ejection fraction\u2014a report from the CHART-2 study","volume":"19","author":"Tsuji","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026012115084488100_ehf212516-bib-0022","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026012115084488100_ehf212516-bib-0023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1475-2840-11-97","article-title":"Insulin resistance and exercise tolerance in heart failure patients: linkage to coronary flow reserve and peripheral vascular function","volume":"11","author":"Snoer","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"2026012115084488100_ehf212516-bib-0024","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/c9e78482-03d2-4cc3-b971-7d91f6ac6cab","article-title":"Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis","volume":"8","author":"Goto","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012115084488100_ehf212516-bib-0025","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/archinte.168.15.1699","article-title":"The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program","volume":"168","author":"Gerstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"2026012115084488100_ehf212516-bib-0026","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1253\/circj.CJ-15-0096","article-title":"Prognostic impact of diabetes mellitus in chronic heart failure according to presence of ischemic heart disease\u2014with special reference to nephropathy","volume":"79","author":"Miura","year":"2015","journal-title":"Circ J"},{"key":"2026012115084488100_ehf212516-bib-0027","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0735-1097(01)01408-5","article-title":"Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction","volume":"38","author":"Dries","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026012115084488100_ehf212516-bib-0028","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","article-title":"Albuminuria in chronic heart failure: prevalence and prognostic importance","volume":"374","author":"Jackson","year":"2009","journal-title":"Lancet"},{"key":"2026012115084488100_ehf212516-bib-0029","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/eurjhf\/hfs001","article-title":"Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study","volume":"14","author":"Miura","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012115084488100_ehf212516-bib-0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012115084488100_ehf212516-bib-0031","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"2026012115084488100_ehf212516-bib-0032","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.161.3.397","article-title":"Glucose tolerance and cardiovascular mortality: comparison of fasting and 2 h diagnostic criteria","volume":"161","author":"Decode Study Group tEDEG","year":"2001","journal-title":"Arch Intern Med"},{"key":"2026012115084488100_ehf212516-bib-0033","doi-asserted-by":"crossref","first-page":"688","DOI":"10.2337\/diacare.26.3.688","article-title":"Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?","volume":"26","author":"Decode Study Group EDEG","year":"2003","journal-title":"Diabetes Care"},{"key":"2026012115084488100_ehf212516-bib-0034","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026012115084488100_ehf212516-bib-0035","first-page":"5","volume-title":"Kidney Int Suppl (2011)","author":"Summary of Recommendation Statements","year":"2013"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12516","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12516","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12516","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/am-pdf\/10.1002%2Fehf2.12516","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/6\/1252\/66136044\/eschf_6_6_1252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/6\/6\/1252\/66136044\/eschf_6_6_1252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:10:58Z","timestamp":1769026258000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/6\/6\/1252\/8403500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,10,24]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12516","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"2019-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}